AIHW National Perinatal Epidemiology and Statistics Unit, 2014

Assisted Reproductive Technology in Australia and New Zealand 2012

Macaldowie A, Wang YA, Chambers GM, Sullivan EA

Read at source

Key figures

Treatment activity, 2012

Measure Value Source
Total ART treatment cycles performed in Australia and New Zealand, 2012 70,082 Summary
ART treatment cycles performed in Australia, 2012 64,905 Summary
ART treatment cycles performed in New Zealand, 2012 5,177 Summary
Increase in ART treatment cycles in Australia compared with 2011 5.8% Summary
Decrease in ART treatment cycles in New Zealand compared with 2011 0.2% Summary
ART treatments using a woman's own oocytes or embryos (autologous), 2012 95.2% Summary
ART cycles using frozen/thawed embryos, 2012 34.8% Summary
Women who undertook autologous fresh and/or thaw ART cycles, 2012 36,171 Summary
Average number of autologous fresh and/or thaw ART cycles per woman, 2012 1.8 Summary
Fresh cycles among autologous ART cycles, 2012 42,299 (63.4%) Treatment overview

Pregnancy and birth outcomes, 2012

Measure Value Source
Clinical pregnancy rate per initiated ART cycle, 2012 23.9% Summary
Live delivery rate per initiated ART cycle, 2012 17.9% Summary
Live delivery rate per initiated autologous fresh cycle, 2012 16.7% Summary
Live delivery rate per autologous fresh embryo transfer, 2012 22.8% Summary
Live delivery rate per initiated autologous thaw cycle, 2012 20.5% Summary
Live delivery rate per autologous thaw embryo transfer, 2012 22.2% Summary
Live delivery rate for women under 30, autologous fresh and thaw cycles combined, 2012 26.0% Summary
Live delivery rate for women over 44, autologous fresh cycles, 2012 0.9% Summary
Live delivery rate for women over 44, autologous thaw cycles, 2012 4.6% Summary

Babies born and multiples, 2012

Measure Value Source
Babies born following ART treatment, 2012 13,590 Summary
Liveborn babies following ART treatment, 2012 13,312 Summary
Liveborn babies that were full-term singletons of normal birthweight, 2012 76.4% Summary

Patient age, 2012

Measure Value Source
Women undergoing an autologous ART cycle aged 40 or older, 2012 approximately 25.3% Summary
Average age of women undergoing autologous ART cycles, 2012 35.8 Summary

Cycle-specific live birth, first ART cycle cohort (started 2009)

Measure Value Source
Women in cohort followed from first autologous fresh ART cycle, starting 2009 16,565 Cycle-specific success rates
Cycle-specific live delivery rate in first autologous fresh ART cycle, cohort started 2009 21.1% Cycle-specific success rates

Multiple births, 2008 to 2012

Measure Value Source
Multiple delivery rate for ART, Australia and New Zealand combined 8.4% to 6.5% Summary
Multiple delivery rate for ART in Australia, 2012 6.6% Summary
Multiple delivery rate for ART in New Zealand, 2012 5.2% Summary

Embryo transfer practice, 2008 to 2012

Measure Value Source
Single embryo transfer (SET) proportion of ART cycles 67.8% to 76.3% Summary

Treatment procedure trends, 2008 to 2012

Measure Value Source
Blastocyst transfer proportion of ART cycles 42.0% to 59.8% Summary
ICSI use proportion of ART cycles 59.1% to 64.7% Summary

Our summary of the report's published figures, each citing its table, figure or section. The full report is at the publisher's link.

Topics

Macaldowie et al. 2014, Macaldowie 2014

Related articles